Pharmafile Logo

VBH

- PMLiVE

The Directory and digital round-up

SOPHiA Genetics acquires IBS, Kyomed becomes KYomed INNOV and launches ePRO, Medtronic unveil diabetes app

- PMLiVE

NHS could save £7bn with greater diagnostics use

Report suggests IVD tests could be key to big savings

PEGASUS OPENS THE HEALTHCARE INSIGHTS STAGE AT CANNES LIONS

Integrated communications agency, Pegasus opened the Healthcare Insights Stage at Cannes Lions today (Monday 18th June) with a speech that explored how organisations and academics can work better together to...

Evoke Mind+Matter

- PMLiVE

New trial results suggest CAR-T effects are durable in lymphoma

Novartis and Celgene/Juno release longer term data on important lymphoma indication at EHA

- PMLiVE

British Business Bank sets up £2.5bn fund for ‘unicorn’ firms

UK government says the private sector will bring in another £5bn in investments

- PMLiVE

Novartis bribery probe in Greece ‘could affect general election’

The pharma giant allegedly gave “bundles of cash” to civil servants, doctors and politicians

- PMLiVE

Does disruptive thinking leave you feeling threatened?

What it takes to change healthcare

- PMLiVE

Changes to look out for in Medical Devices Regulations

Will digital lead to a greater compliance burden?

- PMLiVE

Brave real world? How healthcare communication needs to adapt

The evaluation of drugs and medical devices has moved into a new era. Randomised clinical trials (RCTs) remain the gold standard for evaluating efficacy and safety, however, their limitations are...

- PMLiVE

Protecting patient privacy

The most effective approaches  to compliance

- PMLiVE

ICER says price of Amgen/Novartis’ Aimovig is OK – if used last-line

Recommends the drug should only be used in patients who have exhausted other prevention options

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links